EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 2nd, 2017 • Edge Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 2nd, 2017 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of February 21, 2017 (the “Effective Date”) by and between Edge Therapeutics, Inc., a Delaware corporation (the “Company”), and Alyssa Wyant (“Executive”).
EXECUTIVE STOCK OPTION AGREEMENT UNDER THE EDGE THERAPEUTICS, INC.Executive Stock Option Agreement • March 2nd, 2017 • Edge Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 2nd, 2017 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (this “Agreement”) between Edge Therapeutics, Inc. (the “Corporation” or the “Company”) and the individual specified on the Notice of Grant (the “Optionee”) is made as of the date of grant specified on the Notice of Grant to which this Agreement is attached (the “Grant Notice”). The date of grant specified on the Grant Notice is referred to herein as the “Grant Date.”
EMPLOYEE1 STOCK OPTION AGREEMENT UNDER THE EDGE THERAPEUTICS, INC.Stock Option Agreement • March 2nd, 2017 • Edge Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 2nd, 2017 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (this “Agreement”) between Edge Therapeutics, Inc. (the “Corporation” or the “company”) and the individual specified on the Notice of Grant (the “Optionee”) is made as of the date of grant specified on the Notice of Grant to which this Agreement is attached (the “Grant Notice”). The date of grant specified on the Grant Notice is referred to herein as the “Grant Date.”